Michael Feld - Nov 26, 2025 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP, CRO & Pres. Life Sciences
Signature
Donna Kalazdy, by power of attorney from Michael Feld
Stock symbol
BDX
Transactions as of
Nov 26, 2025
Transactions value $
$0
Form type
4
Date filed
12/1/2025, 12:06 PM
Previous filing
Oct 28, 2025
Next filing
Dec 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feld Michael EVP, CRO & Pres. Life Sciences C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES Donna Kalazdy, by power of attorney from Michael Feld 2025-12-01 0002034349

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +8.83K +107.08% $0.00 17.1K Nov 26, 2025 Direct F1
transaction BDX Common Stock Tax liability $0 -419 -2.45% $0.00 16.7K Nov 26, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.